NASDAQ:IVF INVO Fertility (IVF) Stock Price, News & Analysis $1.88 +0.18 (+10.59%) Closing price 05/29/2026 04:00 PM EasternExtended Trading$2.00 +0.12 (+6.38%) As of 05/29/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About INVO Fertility Stock (NASDAQ:IVF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get INVO Fertility alerts:Sign Up Key Stats Today's Range$1.67▼$1.9150-Day Range$1.43▼$3.5552-Week Range$1.38▼$210.00Volume11.94 million shsAverage Volume48,214 shsMarket Capitalization$3.05 millionP/E RatioN/ADividend YieldN/APrice Target$20.00Consensus RatingModerate Buy Company Overview INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques. The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation. By leveraging the natural conditions of the patient’s body, the INVOcell system aims to reduce the complexity, equipment requirements and cost associated with standard IVF lab procedures. INVO Fertility also provides complementary consumables and training programs to support fertility specialists in adopting its technology. Originating in the early 2010s, INVO Fertility evolved from pioneering in-vivo fertilization research. The company secured U.S. Food and Drug Administration clearance for the INVOcell device in May 2015, marking a significant milestone that enabled commercial distribution. Since then, it has continued to expand its product portfolio and clinical support services to address the needs of fertility clinics and patients worldwide. INVO Fertility markets and distributes its solutions across the United States and through a network of international partners in regions including Latin America, Europe, Asia-Pacific and the Middle East. The company collaborates with reproductive health professionals to provide hands-on training, technical assistance and ongoing clinical support, aiming to broaden access to cost-effective fertility treatment options globally.AI Generated. May Contain Errors. Read More INVO Fertility Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks45th Percentile Overall ScoreIVF MarketRank™: INVO Fertility scored higher than 45% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingModerate Buy Consensus RatingINVO Fertility has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.Upside PotentialINVO Fertility has a consensus price target of $20.00, representing about 963.8% upside from its current price of $1.88.Amount of Analyst CoverageINVO Fertility has only been the subject of 1 research reports in the past 90 days.Read more about INVO Fertility's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of INVO Fertility is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of INVO Fertility is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.68% of the float of INVO Fertility has been sold short.Short Interest Ratio / Days to CoverINVO Fertility has a short interest ratio ("days to cover") of 2.64, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in INVO Fertility has recently increased by 17.19%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldINVO Fertility does not currently pay a dividend.Dividend GrowthINVO Fertility does not have a long track record of dividend growth. News and Social Media4.3 / 5News SentimentN/A News SentimentINVO Fertility has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.83 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for INVO Fertility this week, compared to 2 articles on an average week.Search Interest2 people have searched for IVF on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added INVO Fertility to their MarketBeat watchlist in the last 30 days. Company Ownership0.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, INVO Fertility insiders have not sold or bought any company stock.Percentage Held by Insiders0.72% of the stock of INVO Fertility is held by insiders.Percentage Held by Institutions12.02% of the stock of INVO Fertility is held by institutions.Read more about INVO Fertility's insider trading history. Receive IVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for INVO Fertility and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IVF Stock News HeadlinesINVO Fertility (NASDAQ:IVF) Stock Price Down 6% - Here's What HappenedMay 22, 2026 | americanbankingnews.comINVO Fertility Discloses Delay In Quarterly FilingMay 20, 2026 | theglobeandmail.comMusk takes on IranIranian drones have struck Amazon's data centers, with Microsoft, Google, Oracle, and Nvidia reportedly next on the list. Forbes calls it the start of 'the next AI arms race' - focused on fortifying data center infrastructure. Tech investor Jeff Brown - a former senior executive at Qualcomm, Juniper Networks, and NXP Semiconductors - says Elon Musk already has FCC-approved solution in place. A tiny chipmaker, 148 times smaller than NVIDIA, is positioned to supply Musk 5 billion chips over the next two years, with a potential $12.8 trillion wealth opportunity on the line.May 30 at 1:00 AM | Brownstone Research (Ad)INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-KApril 29, 2026 | globenewswire.comINVO Fertility (IVF) price target increased by 400.00% to 20.40April 10, 2026 | msn.comINVO Fertility Delays Annual 10-K FilingApril 1, 2026 | tipranks.comINVO Fertility, Inc.: INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026March 25, 2026 | finanznachrichten.deINVO Fertility, Inc. Announces 1-for-5 Reverse Stock Split Effective March 27, 2026March 25, 2026 | quiverquant.comQSee More Headlines IVF Stock Analysis - Frequently Asked Questions How have IVF shares performed this year? INVO Fertility's stock was trading at $3.7630 at the beginning of the year. Since then, IVF stock has decreased by 50.0% and is now trading at $1.88. How were INVO Fertility's earnings last quarter? INVO Fertility, Inc (NASDAQ:IVF) issued its earnings results on Thursday, August, 14th. The company reported ($318.00) EPS for the quarter. The business had revenue of $1.86 million for the quarter. When did INVO Fertility's stock split? Shares of INVO Fertility reverse split on Friday, November 28th 2025.The 1-8 reverse split was announced on Tuesday, November 25th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of INVO Fertility? Shares of IVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/14/2025Today5/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (42m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 IVF's financial health is in the Red zone, according to TradeSmith. IVF has been in this zone for over 42 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:IVF Previous SymbolNASDAQ:INVO CIK1417926 Webwww.invobioscience.com Phone(978) 878-9505FaxN/AEmployees10Year Founded2009Price Target and Rating Average Price Target for INVO Fertility$20.00 High Price Target$20.00 Low Price Target$20.00 Potential Upside/Downside+963.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($3,151.46) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$9.10 million Net Margins-417.02% Pretax Margin-387.90% Return on EquityN/A Return on Assets-92.42% Debt Debt-to-Equity RatioN/A Current Ratio0.12 Quick Ratio0.10 Sales & Book Value Annual Sales$6.53 million Price / Sales0.47 Cash FlowN/A Price / Cash FlowN/A Book Value($3,583.22) per share Price / Book0.00Miscellaneous Outstanding Shares1,620,000Free Float1,603,000Market Cap$3.05 million OptionableNo Data Beta2.31 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (NASDAQ:IVF) was last updated on 5/30/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredPresident Trump just sparked a stock market MELT UPThe real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...Stansberry Research | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredSkip the Line Opportunity: The SpaceX IPOFormer tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...Brownstone Research | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Fertility, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Fertility With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IVF Stock Alerts